CREATINE KINASE OTHER DIAGNOSTIC SIGNIFICANCE o Associated with ATP generation in contractile o AMI (Acute Myocardial Infarction) system (muscular system) o Muscular Dystrophy-Duchenne Type – highest o FUNCTION: in the muscle cells it stores Creatine concentration of CK-MB is seen; as high as 50-100x phosphate that is important in ATP production the upper limit of CK o Non-specific o CVA (stroke) & other brain conditions Creatine phosphate + ADP ← → Creatine +ATP o Hypothyroidism, malignant hyperpyrexia, Reye’s MAJOR TISSUE SOURCES: syndrome, Vibrio Vulnificus 1. Skeletal muscle ATYPICAL FORM OF CK (ABNORMAL ENZYME) 2. Heart muscle MACRO CK 3. Brain tissue o Found midway between MM AND MB ISOENZYMES: dimer with two sub-units o Two theories: CK-1 (CK-BB) → < 1% - brain type (most anodal) ▪ CK-BB is bound to IgG CK-2 (CK-MB) → < 6% - hybrid type ▪ CK-MM is bound to lipoproteins CK-3 (CK-MM) → 94-100% - muscle type (least anodal o No clinical significance except that it is related to age but most cathodal) and sex; seen in female of >50 years old ISOENZYMES MITOCHONDRIAL CK (CK-MI) CK-MM o Found before the MM o Major fraction in serum o Bound to the exterior surface of mitochondrial o Elevated also in hypothyroidism, muscle activity, IM membrane of the Muscle, brain, & liver. injection o indicator of severe illness, malignant tumors, and ▪ Hypothyroidism – increase membrane cardiac abnormalities permeability, decrease CK clearance due to slow METHODS USED FOR THE MEASUREMENT OF metabolism ISOENZYMES OF CK ▪ Muscle activity – due to vigorous exercise and o ELECTROPHORESIS – considered as reference intramuscular injection method o Found in skeletal muscles and cardiac muscles o ION EXCHANGE CHROMATOGRAPHY CK-BB ▪ More sensitive and pricey o Seldomly found in the plasma or circulation ▪ Problem with the bad column: CK-MM merge ▪ Short half-life:1-5 hours with CK-MB ▪ Have a high molecular size that is why it cannot ▪ CK-BB eluted with CK-MB past through the blood brain barrier o ANTIBODIES – used specifically for CK-MB o Confined in the brain due to the blood brain barrier determination and diagnosis of AMI o increase only when there is a brain injury ▪ ANTI-M ANTIBODY inhibits all the activity of M CK-MB subunit. o Most important among the isoenzymes of CK ▪ To get the entire activity of the CK-MB, multiply o 20% of cardiac tissue contains CK-MB, and very little the activity of CK-B into 2 to other tissues o IMMUNOASSAY o Myocardium is the only tissue from which CK-MB ▪ Detects MB reliably with minimal reactivity enters the serum, meaning it is quite specific to the ▪ Detects enzyme protein rather than activity heart muscle METHODS FOR THE DETRMINATION OF CK o Only myocardium can increase the level of CK-MB in TONSER-GILBERG ASSAY (9.0 AT 340NM) the blood. Creatinine + ATP ←CK→ Creatine phosphate + ADP o Indicator of myocardial damage (AMI or heart attack) (forward or direct reaction) o RISE = 4-8hrs ADP + Phosphoenolpyruvate ←phosphokinase→ o PEAK = 12-24hrs pyruvate + ATP o NORMALIZE = 48-72hrs Pyruvate + NADH + H ←lactate dehydrogenase→ ▪ OTHER CARDIAC MARKERS: LDH, AST, troponin lactate + NAD (not an enzyme but much specific and sensitive) OLIVER-ROSALKI ASSAY (6.8 AT 340NM) 3. SUBSTRATE AFFINITY Creatinine phosphate + ADP ←CK→ Creatinine + ATP DIAGNOSTIC SIGNIFICANCE (reverse or indirect method) o ELEVATED LEVEL: Renal, hepatic, cardiac, skeletal, ATP + glucose ←hexokinase→ ADP + G6P hematologic, & neoplastic disorder G6P + NADPH ←G6PD→ 6-phosphogluconate + NADPH o HIGHEST LEVEL: pernicious and hemolytic disorder o When measuring CK, avoid hemolysis of RBC will o Serves as a cardiac marker release adenylate kinase because it will give false AMI elevated values. o RISE: 12-24 hours o Storage o PEAK: 48-72 hours ▪ 4C: up to 7 days o NORMALIZE: after 10 days ▪ -20C: up to 1 month METHODS o Reference value 1. WACKER METHOD (8.3-8.9 AT 340 NM) ▪ Male: 15-160 U/L ▪ Forward or direct reaction ▪ Female: 15-130 U/L 2. WROBLEUSKI AND LA DUE (7.1-7.4 AT 340NM) ▪ CK-MB: <6% ▪ Reverse or indirect reaction LACTATE DEHYDROGENASE (LDH) ▪ 3 times faster, small sample is needed o Catalyzes the interconversion of lactic acid and ▪ Susceptible to substrate exhaustion & loss of pyruvic acid linearity o Can convert lactic acid to pyruvic acid and vice-versa o Avoid hemolysis because RBC contains 100-150x the Lactate + NAD ←LDH→ Pyruvate + NADH concentration of the LDH inside the red cells o COENZYME: NAD o LDH is a cold labile enzyme (stored at room ISOENZYMES temperature) Tetrametric molecules containing 4 subunits of two o LD5 – most labile possible forms; nonspecific REFERENCE VALUE: 100-225 U/L I. LD1 – HHHH 14-26% - RBC and heart ASPARTATE AMINOTRANSFERASE (AST) II. LD2 – HHHM 29 – 39% - RBC and heart o also called the serum glutamic oxaloacetic III. LD3 – HHMM 20-26% - lungs, transaminase (SGOT) lymphocyte, spleen, and o involved in the transfer of amino group between pancreas aspartate and alpha keto acids. IV. LD4 – HMMM 8-16% - liver o COENZYME: pyridoxal phosphate V. LD5 – MMMM 6-16% - skeletal muscle Aspartate + a-ketoglutarate ←AST→ oxaloacetate + o HM – heart and muscle glutamate o LD1 and LD2 – indicators of AMI and intravascular ISOENZYMES hemolysis o Cytoplasmic Isoenzyme o LD3 – indicator of pulmonary disorders o Mitochondrial Isoenzyme o LD4 and LD5 – indicator of intrahepatic disorders and No clinical significance; measured as a whole muscular dystrophies TISSUE SOURCES o Flipped pattern – the concentration of LD1 > LD2 1. Cardiac tissue (AMI/hemolyzed sample) 2. Liver o LD 6 - Alcohol Dehydrogenase (abnormal enzyme) 3. Skeletal muscle ▪ 6TH Band to the electrophoresis AMI ▪ Clinically significant; presence signifies great o RISE: after 6-8 hours after attack prognosis and impending death o PEAK: after 24 hours ▪ Arteriosclerotic cardiovascular failure; can lead o NORMALIZE: after 5 days to liver damage Highest concentration of AST is seen in acute MEASUREMENT OF ISOENZYMES hepatobiliary disorder while in viral hepatitis the 1. ELECTROPHORESIS – widely used method; patten of concentration of AST goes as high 100x the normal value migration is the same as their arrangement of AST and 4x in liver cirrhosis 2. IMMUNOINHIBITION OR CHEMICAL INHIBITION METHOD ▪ Bone and Intestine – co-migrators; to separate Karmen Method – for the determination of AST add muramidase Aspartate + a-ketoglutarate ←AST→ oxaloacetate + 2. HEAT STABILITY TEST – serum is subjected to 56C for glutamate 10-15 minutes Oxaloacetate + NADH + H ←Malate dehydrogenase→ ▪ Most heat stable – placental ALP malate + NAD ▪ Heat labile – bone ALP o Avoid hemolysis because it can increase the value of 3. CHEMICAL INHIBITION TEST AST o Phenylalanine – inhibit activity of placental and o Stored at ref temp – will last up to 3-4 days intestinal ALP REFERENCE RANGE: 5-30 U/L o 3 molar urea – inhibit activity f placental ALP ALANINE AMINOTRANSFERASE o Levamisole – inhibit activity of the bone ALP o Also known as serum glutamic pyruvic transaminase CARCINOPLACENTAL ALP: isoform of the placental ALP or SGPT o REGAN ALP - Lungs, breast, ovaries, o Involved with the transfer of an amino group from gynecological problem alanine to a- ketoglutarate with the formation of o NAGAO ALP - adenocarcinoma of pancreas, bile glutamate and pyruvate duct & pleural cancer o More specific METHOD: bowers & mccomb method (continuous o Has a higher concentration; elevated longer because monitoring technique) of its half life of 16-24 hours during liver disorders p-nitrophenyl phosphate ←ALP→ p-nitrophenol Alanine + a-ketoglutarate ←→ Pyruvate + glutamate and phosphate ion TISSUE SOURCE: Liver REFERENCE VALUE: 30-90U/L Coupled Enzymatic Reaction (7.3 – 7.8 AT 340 nm) INCREASED ALP Alanine + a-ketoglutarate ←ALT→ pyruvate + glutamate o Osteitis deformans – bone ALP Pyruvate + NADH +H ←LD→ lactate + NAD o Obstructive jaundice – liver ALP o Stored at 4C and ay last up 3-4 days o Osteomalacia – bone ALP REFERENCE VALUE: 6-37 U/L o Rickets – bone ALP ALKALINE PHOSPHATASE (ALP) o Bone CA – bone ALP o Catalyze the hydrolysis of various o Sprue – intestinal ALP phosphomonoester at an alkaline pH o Hepatitis and cirrhosis – liver ALP o It functions to liberate inorganic phosphate from an o Hyperparathyroidism organic phosphate ester with the concomitant ACID PHOSPHATASE production of an alcohol. Catalyzes the same reaction made by ALP except that it INHIBITOR: phosphorus is active at acidic pH (5.0) TISSUE SOURCES: intestine, placenta, liver, bone, small MAJOR SOURCE: prostate gland amount in kidney MINOR SOURCES: RBC, platelets, bone ISOENZYMES: intestinal ALP, placental ALP, liver ALP, USES: forensic chemistry, detection of cancer bone ALP METHOD: Shinowara Method – has the same reaction BONE ISOENZYMES → elevated in children specially in for the method of ALP periods of growth; as well in adults older than 50 years Special consideration on enzyme activity old o Prostatic ACP – inhibited by L-tatrate PLACENTAL ISOENZYMES → 16-20 weeks of gestation o Red cell ACP – inhibited by cupric anion and SIGNIFICANCE: formaldehyde o Obstructive jaundice – highest concentration of ALP o Prostatic CA o Paget’s disease/ osteitis deformans – destruction of For more specific diagnosis of prostatic cancer ACP is the bone combined with tumor marker called prostatic specific SEPARATED BY: antigen (PSA) 1. ELECTROPHORESIS REFERENCE VALUE: 2.5 -11.7 U/L (total ACP) ▪ Liver ALP – most anodal but least cathodal 0-3.5 ng/mL (prostatic ACP) ▪ Intestinal ALP – least anodal but most cathodal AMYLASE (AMS/AMY) o Pancreas specific o it catalyzes the breakdown of starch and glycogen; MAJOR TISSUE SOURCE: helps in the digestion of carbohydrates SIGNIFICANCE: o smallest enzyme o Acute pancreatitis o If urine is tested with amylase, it will yield a positive ▪ RISE: after 6 hours result ▪ PEAK: within 24 hours ISOENZYMES: ▪ NORMAL: within 8-14 days o S-TYPE (ptyalin) – salivary glands o Chronic pancreatitis – result in the degradation of o P-TYPE (amylopsin) – pancreas acinar cells leading to the decrease concentration of MAJOR TISSUE SOURCES: salivary glands and pancreas lipase OTHER TISSUE SOURCES: adipose tissue, fallopian tube, METHOD small intestine, skeletal muscle o SUBSTRATE: OLIVE OIL, TRIOLEIN SIGNIFICANCE: o addition of COLIPASE – makes the method become o Acute pancreatitis more sensitive and specific for determination of ▪ RISE: 2-4 hours acute pancreatitis ▪ PEAK: 24 hours o Cherry Crandal method - hydrolysis of olive oil after ▪ NORMALIZE: within 3-5 days incubation for 24 hours at 37 *C & titration of fatty o Parotitis acids using NaOH o Renal failure - increase of amylase to blood because TAG + H2O ←LPS→ monoglyceride and fatty acids of failure of it to be excreted REFERENCE VALUE: 0-1.0 U/mL Macro amylase → abnormal form of amylase; bound to ALDOLASE immunoglobulins splits fructose-1,6-diphosphate into two triose REFERENCE VALUE: 60-180 SU/L phosphate molecules 95-290 U/L ISOENZYMES METHOD Aldolase A → found in the skeletal muscle INHIBITOR: wheat germ lectin (salivary amylase) & TAG Aldolase B → found in the WBC, liver, kidney (serum amylase) Aldolase C → found in the brain SUBSTRATE: starch INCREASE LEVEL: skeletal muscle disease, leukemia, HA, 1. SACCHAROGENIC hepatic carcinomas o Measures the amount of reducing sugar 5’ NUCLEOTIDASE produced by the hydrolysis of starch by the usual Marker for hepatobiliary disease glucose methods. REFERENCE VALUE: 0-1.6 units o Classic reference method expressed in SU. GAMMA GLUTAMYL TRANSFERASE 2. AMYLOCLASTIC – destruction It catalyzes the transfer of glutamyl groups between o Measures AMS activity by following the peptides or amino acid through linkage at a gamma decreases in substrate concentration carboxyl group. (degradation of the starch). SOURCES: liver, kidney, prostate & pancreas 3. CHROMOGENIC – color Sensitive indicator of alcoholism (Occult alcoholism) and o Measures AMS activity by the increase in color acute alcoholic hepatitis intensity of the soluble dye-substrate solution ELEVATED AMONG INDIVIDUAL: warfarin, produced in the reaction. phenobarbital, & phenytoin therapy 4. COUPLED-ENZYME METHOD: Rosalki & Tarrow Method o Measures AMS activity by the continuous SUBSTRATE: gamma- glutamyl-p-nitroanilide monitoring technique REFERENCE VALUE: 5-30 U/L → Female; 6-45U/L → Male ▪ alpha glucosidase, hexokinase and G6PD CHOLINESTERASE/PSEUDOCHOLINESTERASE LIPASE (LPS) o Produced from the liver parenchyma o An enzyme that hydrolyzes the ester linkages of fats o Marker for insecticide or pesticide poisoning to produce alcohol and fatty acid. specifically organophosphate; concentration o Produced by the acinar cell of the pancreas decreases due to these poisoning METHOD: Ellman techniques or potentiometry REFERENCE VALUE: 0.5-1.3 pH unit ANGIOTENSIN CONVERTING ENZYME Also known as the peptidyl dipeptidase A or kininase II INDICATOR OF NEURONAL DYSFUNCTION → specifically Alzheimer’s disease SOURCES: macrophage and epithelioid cells CERULOPLASMIN Copper carrying protein & an enzyme Hepatolenticular disease (Wilson’s’ disease) - decrease value GLUCOSE-6-PHOSPHATE DEHYDROGENASE Deficiency of this enzyme can lead to drug-induced hemolytic anemia (antimalarial drug, primaquine) REFERENCE VALUE: 10-15U/g Hb ORNITHINE CARBAMOYL TRANSFERASE Marker for Hepatobiliary disease 8-20 mU/mL
Fast Facts: Deficiencia de piruvato quinasa para pacientes y familiares: Una enfermedad genética rara que afecta a los glóbulos rojos Información + Asumir el control = El mejor resultado
Fast Facts: Le déficit en pyruvate kinase pour les patients et les accompagnants: Une maladie génétique rare qui affecte les globules rouges Informations + Prise de contrôle = Meilleur résultat
Fast Facts: Pyruvatkinase-Mangel für Patienten und Angehörige: Eine seltene genetische Erkrankung der roten Blutkörperchen Informationen + Mitreden-Können = Bestmöglicher Verlauf